Page 7 - Knight Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Knight Therapeutics Inc (TSE:GUD) Insider Sime Armoyan Buys 351,000 Shares

Knight Therapeutics Inc. (TSE:GUD – Get Free Report) insider Sime Armoyan acquired 351,000 shares of the company’s stock in a transaction that occurred on Monday, March 25th. The stock was acquired at an average price of C$5.25 per share, with a total value of C$1,842,750.00. Sime Armoyan also recently made the following trade(s): On Monday, […]

Sime armoyanRaymond jamesRoyal bankKnight therapeutics incKnight therapeuticsGet free reportTherapeutics incKnight therapeutics dailyTse gudInsider tradingNsider trades

Knight Therapeutics Inc (TSE:GUD) Insider Buys C$1,842,750 00 in Stock

Knight Therapeutics Inc. (TSE:GUD – Get Free Report) insider Sime Armoyan purchased 351,000 shares of Knight Therapeutics stock in a transaction dated Monday, March 25th. The stock was bought at an average price of C$5.25 per share, with a total value of C$1,842,750.00. Sime Armoyan also recently made the following trade(s): On Monday, January 22nd, […]

Raymond jamesSime armoyanKnight therapeutics incRoyal bankKnight therapeuticsGet free reportTherapeutics incKnight therapeutics dailyTse gudInsider tradingNsider trades

Knight Therapeutics Inc ranks on The Globe and Mail s fifth-annual Women Lead Here benchmark of executive gender diversity -March 28, 2024 at 11:04 am EDT

MONTREAL, March 28, 2024 Knight Therapeutics Inc. is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list..

United statesBiotoscana farmaArvind utchanahSamira sakhiaKnight therapeutics incWomen lead hereDawn callejaKnight therapeuticsChief executive officerLead hereTherapeutics incLatin americanUnited medicalAnnual reportAnnual information form

Raymond James Research Analysts Lower Earnings Estimates for Knight Therapeutics Inc (TSE:GUD)

Raymond James Research Analysts Lower Earnings Estimates for Knight Therapeutics Inc (TSE:GUD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sime armoyanRaymond jamesRoyal bankKnight therapeutics company profileKnight therapeutics incKnight therapeuticsFree reportKnight therapeuticGet free reportTherapeutics incKnight therapeutics daily

Knight Therapeutics (TSE:GUD) Price Target Raised to C$7 00

Knight Therapeutics (TSE:GUD – Free Report) had its price objective boosted by Royal Bank of Canada from C$6.50 to C$7.00 in a research report report published on Friday, BayStreet.CA reports. They currently have an outperform rating on the stock. Separately, Raymond James lifted their target price on shares of Knight Therapeutics from C$7.00 to C$7.50 […]

Raymond jamesSime armoyanRoyal bankKnight therapeutics incKnight therapeutics company profileKnight therapeuticsFree reportTherapeutics trading downGet free reportTherapeutics incKnight therapeutics daily